PGEN Precigen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PGEN

Price (delayed)

$7.44

Market cap

$2.66B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.03

Enterprise value

$2.75B

?
Relative Growth: Rel. Growth: 48
Relative Strength: Rel. Strength: 95
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 22

Intrexon Corporation is Powering the Bioindustrial Revolution with Better DNA ® to create biologically-based products that improve the quality of life and the health of the planet through two operating ...

Highlights
Precigen's revenue has soared by 171% from the previous quarter
PGEN's equity has surged by 115% since the previous quarter
Precigen's EPS has shrunk by 145% YoY but it has increased by 13% QoQ
PGEN's quick ratio is up by 45% YoY but it is down by 4.3% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.precigen.com
Peers: NVAX NVCR NBIX

Key stats

What are the main financial stats of PGEN

PGEN stock price

How has the Precigen stock price performed over time
Intraday
-5.7%
1 week
0.07%
1 month
3.33%
1 year
100.54%
YTD
77.99%
QTD
30.53%

Financial performance

How have Precigen's revenue and profit performed over time
Revenue
$85.72M
Gross profit
$77.72M
Operating income
-$39.5M
Net income
-$157.71M
Gross margin
90.7%
Net margin
-184%
Precigen's revenue has soared by 171% from the previous quarter
PGEN's operating margin has soared by 98% YoY and by 84% from the previous quarter
Precigen's net margin has soared by 94% YoY and by 72% from the previous quarter
Precigen's operating income has soared by 62% YoY and by 58% from the previous quarter

Price vs fundamentals

How does PGEN's price correlate with its fundamentals

Growth

What is Precigen's growth rate over time

Valuation

What is Precigen stock price valuation
P/E
N/A
P/B
60.87
P/S
30.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
32.03
Precigen's EPS has shrunk by 145% YoY but it has increased by 13% QoQ
PGEN's equity has surged by 115% since the previous quarter
PGEN's P/B is 24% above its last 4 quarters average of 52.1
Precigen's revenue has soared by 171% from the previous quarter
PGEN's P/S is 64% below its last 4 quarters average of 90.6 and 44% below its 5-year quarterly average of 58.5

Efficiency

How efficient is Precigen business performance
The ROA has plunged by 95% YoY but it has grown by 22% from the previous quarter
Precigen's return on sales has surged by 94% YoY and by 72% QoQ
PGEN's return on equity has surged by 68% since the previous quarter and by 8% year-on-year
The ROIC has soared by 66% YoY and by 40% from the previous quarter

Dividends

What is PGEN's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Precigen financials performed over time
The company's total assets is 34% higher than its total liabilities
PGEN's current ratio has surged by 69% year-on-year but it is down by 5% since the previous quarter
The company's total assets has surged by 67% YoY and by 23% QoQ
Precigen's debt is 126% more than its equity
PGEN's equity has surged by 115% since the previous quarter
PGEN's debt to equity has plunged by 53% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.